Qingyong Li Selected Research

Qingyong Li Research Topics

Disease

14	Neoplasms (Cancer) 12/2022 - 11/2006
5	Breast Neoplasms (Breast Cancer) 06/2022 - 04/2014
4	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 05/2019
3	Hepatocellular Carcinoma (Hepatoma) 03/2015 - 09/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 02/2012
2	Liver Neoplasms (Liver Cancer) 01/2019 - 01/2015
2	Periodontitis 01/2019 - 08/2017
2	Hyperuricemia 01/2018 - 01/2018
1	Neuroinflammatory Diseases 06/2022
1	Hemorrhagic Stroke 01/2021
1	Hemorrhage 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020
1	Infections 03/2020
1	Acne Vulgaris 10/2019
1	Diabetic Cardiomyopathies 08/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Periodontal Pocket (Periodontal Pockets) 01/2019
1	Bone Resorption 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 03/2015
1	Body Weight (Weight, Body) 04/2014
1	Carcinoma (Carcinomatosis) 04/2013
1	Body Weight Changes 02/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2012

Drug/Important Bio-Agent (IBA)

6	CamptothecinIBA 06/2022 - 09/2011
5	Pharmaceutical PreparationsIBA 12/2022 - 09/2011
5	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019 - 09/2011
4	Peptides (Polypeptides)IBA 12/2022 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2017
3	Topotecan (Hycamtin)FDA LinkGeneric 06/2022 - 04/2014
3	HydrogelsIBA 10/2019 - 08/2017
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2022 - 01/2017
2	7- ethyl- 7- hydroxy- 10H- 1,3- Dioxolo(4,5- g)pyrano(3',4':6,7)indolizino(1,2- b)quinoline- 8,11(7H,12H)- dioneIBA 06/2022 - 11/2020
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2019 - 01/2019
2	Tolonium Chloride FDA Link 10/2019 - 01/2019
2	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2019 - 07/2014
2	Protein Hydrolysates FDA Link 01/2018 - 01/2018
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2017 - 11/2006
2	Human Serum Albumin FDA LinkGeneric 01/2016 - 01/2011
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016 - 01/2011
2	homocamptothecinIBA 01/2016 - 01/2011
2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 04/2014 - 02/2012
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2022
1	Monoclonal AntibodiesIBA 12/2022
1	asparaginylendopeptidase (legumain)IBA 12/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2022
1	Immunoconjugates (Immunoconjugate)IBA 12/2022
1	SynaptophysinIBA 06/2022
1	Adenosine Triphosphate (ATP)IBA 06/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	HomocysteineIBA 01/2021
1	NucleotidesIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	SurvivinIBA 11/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020
1	Attenuated VaccinesIBA 03/2020
1	Long Noncoding RNAIBA 08/2019
1	Amyloid beta-PeptidesIBA 05/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Metronidazole (Metric)FDA LinkGeneric 01/2019
1	CollagenIBA 01/2019
1	Gout Suppressants (Antigout Agents)IBA 01/2018
1	potassium oxonateIBA 01/2018
1	hydroxycamptothecinumIBA 01/2016
1	CurcuminIBA 03/2015
1	AntioxidantsIBA 03/2015
1	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA 03/2015
1	ArtesunateIBA 01/2015
1	EstersIBA 04/2014
1	AnionsIBA 01/2014
1	BerberineIBA 04/2013
1	CaspasesIBA 04/2013
1	coenzyme Q10 (CoQ10)IBA 02/2012
1	Lysine (L-Lysine)FDA Link 09/2011
1	10-hydroxycamptothecinIBA 01/2011
1	SolutionsIBA 01/2009
1	Phosphates (Orthophosphate)IBA 01/2009
1	LactonesIBA 01/2009

Therapy/Procedure

6	Therapeutics 12/2022 - 09/2011
3	Photochemotherapy (Photodynamic Therapy) 10/2019 - 08/2017
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2011